Vosevi® (28 tabs) is a prescription medicine approved by the FDA & EMA for the treatment of chronic Hepatitis C across all genotypes in adults with or without liver cirrhosis (compensated) who failed previous treatments with certain advanced Hep C regimens. Vosevi overall established cure rate across all 6 strains of Hepatitis C is about 97%.
- Vosevi® side effects profile is quite mild especially with enough water intake
- Consult a doctor before concurrent administration of other drugs and supplements
- Vosevi® is contraindicated in patients taking the drug Rifampin
Active Ingredients : Sofosbuvir 400 mg / Velpatasvir 100 mg / Voxilaprevir 100 mg
Manufactured by Gilead Sciences Inc®